Evidence map›Paper›PMID 33494813›Full record

ArticleStem cell research & therapy2021

Skin regeneration is accelerated by a lower dose of multipotent mesenchymal stromal/stem cells-a paradigm change.

Gertraud Eylert, Reinhard Dolp, Alexandra Parousis, Richard Cheng, Christopher Auger, Magdalena Holter, Ingrid Lang-Olip, Viola Reiner, Lars-Peter Kamolz, Marc G Jeschke

Erratum issuedAbstract read
In one paragraph

Article in Stem cell research & therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Porcine Wound Models: The Gold Standard for Translational Research in Cutaneous Healing.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Gertraud EylertSunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada.ORCID http://orcid.org/0000-0002-2312-4992
Reinhard DolpSunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada.
Alexandra ParousisSunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada.
Richard ChengInstitute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Canada.
Christopher AugerSunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada.
Magdalena HolterInstitute of Biostatistics, Medical University of Graz, Graz, Austria.
Ingrid Lang-OlipDivision of Cell Biology, Histology, Embryology, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria.
Viola ReinerDivision of Cell Biology, Histology, Embryology, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria.
Lars-Peter KamolzDivision of Plastic, Aesthetic, Reconstructive Surgery, Medical University of Graz, Graz, Austria.
Marc G JeschkeSunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada. Marc.Jeschke@sunnybrook.ca.

Funding

Hepatic ER stress contributes to morbidity and mortality after burn injury.R01GM087285 · NIGMS · SUNNYBROOK & WOMEN'S COLL HLTH SCIS CTR · PI BOEHNING, DARREN F, JESCHKE, MARC GERHARD · 2010 to 2018
$1.9M
CIHR 123336NIGMS NIH HHS R01 GM087285
6 · The paper itself

Abstract

backgroundMultipotent mesenchymal stromal/stem cell (MSC) therapy is under investigation in promising (pre-)clinical trials for wound healing, which is crucial for survival; however, the optimal cell dosage remains unknown. The aim was to investigate the efficacy of different low-to-high MSC dosages incorporated in a biodegradable collagen-based dermal regeneration template (DRT) Integra®.

methodsWe conducted a porcine study (N = 8 Yorkshire pigs) and seeded between 200 and 2,000,000 cells/cm

resultWe found that the low dose range between 200 and 40,000 cells/cm

conclusionThis regenerative cell therapy study using MSCs shows efficacy toward a low dose, which changes the paradigm that more cells lead to better wound healing outcome.

Indexed as

BurnsMesenchymal Stem CellsMesenchymal Stem Cell TransplantationAnimalsSkinSwineUmbilical CordWound HealingCell therapyExperimental surgeryIntegraMultipotent mesenchymal stromal/stem cellsSkin regenerationSkin substitutesTissue engineeringUmbilical cord mesenchymal stromal/stem cellsWound healing

Identifiers

PMID33494813
PMCPMC7831169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.